No abstract available
Publication types
-
Clinical Trial, Phase I
-
Letter
MeSH terms
-
Aged
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / immunology
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Exanthema / chemically induced
-
Fatigue / chemically induced
-
Female
-
Humans
-
Male
-
Middle Aged
-
Primary Myelofibrosis / drug therapy*
-
Transforming Growth Factor beta / antagonists & inhibitors*
-
Transforming Growth Factor beta / immunology
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Transforming Growth Factor beta
-
fresolimumab
Associated data
-
ClinicalTrials.gov/NCT01291784